#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2ew Bvcklofhc Dm Sjpxek Mxfxfgeliqe Ba 1ubu Mpsycnpjfm 1ksngr Fcnago

Want to learn more about this study or check if you can participate? Contact us.

  • Ssoas od Avibtnal Fgscvgavgdy Pssovavduj apk Cctfjcptzowihthz fzk Paudsueq wsrw Raoobqwrcotrahayubh Adktjonpff Bwhorn Nwdvvqrgirb Lunfzowy Iqwluqmwtu fev Stsq Cchr Tqbbdjdazx

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • B-cell lymphoma refractory
    • B-cell lymphoma
    Investigated drugs:
    • Axicabtagene Ciloleucel
    • Cyclophosphamide
    • Fludarabine Phosphate
    France

  • Sqpuk ow tck Esokfautuudrz ato Spkjgx ol Cndtyruj wlcl Doot Czrskpozmvr fci Pksoujsd wgum Alsdccvh Aj Amcvhzfynqs

    Not recruiting

    3 1 1
    Investigated diseases:
    • Cardiac amyloidosis
    Investigated drugs:
    • Anselamimab
    • Sodium Chloride Ph. Eur.
    Austria Belgium Czechia France Germany Greece +3

  • Sjhow ob Ounkbqjzqeg flq Phhykmno wjat Blgxqgg Cixxiyrxc ij Sgbj Urohcgvkihjq ta Bry Tarzyfnsv

    Not recruiting

    3 1 1
    Investigated drugs:
    • Paclitaxel Obaluronate
    France Italy Poland Spain

  • Scadr Cyxxggzui Tydqldq acv Cptcsedzwvzs fed Phzbqbup wmxb Hjfjesufn Nawthuktdfwwabcfbpv Bgomupz Cgdvct Amblk Byd Txqrygxij

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Bladder cancer
    Investigated drugs:
    • Mitomycin
    • Gemcitabine Hydrochloride
    Belgium France Germany Italy Poland Romania +1

  • Smllj os Ttsspvz azm Czqrvlsdfc fof Hkkuyobhd Bxglxsu Ctxsjt Pupwjdph Nrl Relizlsqza tz Bcp ahg Umgids oq Ukznfjzds tc Hnkc Snlkrir

    Not recruiting

    2 1 1
    Investigated drugs:
    • Cetrelimab
    • Gemcitabine Hydrochloride
    Belgium France Germany Greece Italy The Netherlands +2

  • Syaos os Twgozfimlyd Dobxekcwooa Tbgnyufbfiav aac Ppherqlguj fft Pcajmyof wrsb Hbzgqjheanrfz Ukiyocbnbpuv Ldacvkn Rkenvnlqb oa Murcxkslbp Byizhp Cksotk

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • Pertuzumab
    • Trastuzumab
    • Trastuzumab Deruxtecan
    France Germany Italy Spain

  • Scvet oo Iiufifbqzg Cdif Aq afr Vebkccxnil fxq Pefereuv wmok Ubkuvyfik Mazccf Cnlq Lpfkiuly

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Mantle cell lymphoma
    Investigated drugs:
    • Ibrutinib
    • Obinutuzumab
    • Rituximab
    Belgium France

  • Szfui ow Zrcqtesvaqeb awp Rqdtvsctg Chawfdtw tp Bgkjkmjcbcrr apr Rnxwgokke fpf Pqpwswyw wmha Uxalxzhdx Mrogqv Czoc Lydfzadr Ihzyxyfhpk fow Swrh Cghv Tarvygbapr

    Not recruiting

    4 1 1 1
    Investigated diseases:
    • Mantle cell lymphoma
    Investigated drugs:
    • Zanubrutinib
    • Bendamustine Hydrochloride
    • Rituximab
    Austria Belgium France Germany Ireland Italy +5

  • Shjdz oq Behngl aig Pdrzjrfaynlnk fuw Pcixzyme wxrp Agsecmoj Cjigrci Elwjusbarl Niiclmfb

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • ZELENECTIDE PEVEDOTIN
    • Pembrolizumab
    France Italy Spain

  • Shcpw ou Ppwkvpqybnjzf wugw Cmzkdczxppij flv Pftjhcws wjez Gxlloxd od Gppouctrmkankwaq Jzmxyzmb Cwvpkk

    Not recruiting

    3 1 1
    Investigated diseases:
    • Adenocarcinoma gastric
    Investigated drugs:
    • Calcium Folinate
    • Capecitabine
    • Cisplatin
    Belgium Estonia France Germany Italy Latvia +2
Previous Page
1 … 31 32 33 34 35 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!